VWF gene analysis ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 288 | Autoimmune acquired coagulation factor deficiency | 1 |
288. Autoimmune acquired coagulation factor deficiency
Clinical trials : 206 / Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02869074 (ClinicalTrials.gov) | October 3, 2017 | 29/7/2016 | Molecular and Clinical Profile of Von Willebrand Disease in Spain | Molecular and Clinical Profile of Von Willebrand Disease (VWD) in Spain (PCM-EVW-ES). Recruitment Extension, Further Data Analysis, Improvement of Registry Platform, Diagnosis and Management of VWD Application Development | Von Willebrand Disease | Genetic: VWF gene analysis | Spanish Society of Thrombosis and Haemostasis | Francisco Vidal Pérez;Maria Fernanda López Fernández;Almudena Pérez Rodríguez;Irene Corrales Insa;Ana Rosa Cid Haro | Recruiting | 2 Years | 80 Years | All | 400 | Spain |